In cases where tumors have developed resistance to conventional chemotherapy, anti-PD-1/PD-L1 agents have been demonstrated to effectively inhibit tumor growth by subtly modulating the interaction between immune cells and tumor cells. Here, PDCD1 is linked to neoplasm.